Teriparatide (Forsteo®), behandeling osteoporose


1. Productinformatie teriparatide (Forsteo®) via: www.emea.europa.eu, human medicines, EPARs.
2. Neer RM, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-1441.
3. Body J-J, et al. A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2002; 87: 4528-4535. 

Auteurs

  • dr D. Bijl